Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -58.20 -3.88% 1,443.00 1,439.40 1,441.20 1,490.00 1,420.80 1,485.40 17,998,685 16:35:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 33,754.0 6,221.0 93.9 15.4 72,396

Glaxosmithkline Share Discussion Threads

Showing 19226 to 19249 of 21075 messages
Chat Pages: Latest  771  770  769  768  767  766  765  764  763  762  761  760  Older
DateSubjectAuthorDiscuss
12/2/2019
14:19
When the GSK President of global vaccines sells, even before ex dividend date, not that encouraging.
montyhedge
12/2/2019
14:07
Would have been just about the days low so well done on that. TM is one of the more credible posters on here that doesn't have a retrospective broker that others seem to use.
dr biotech
12/2/2019
14:05
I sold my GSK at 1560p see what happens, switched into IAG (British Airways) looks cheap to me and no stamp duty to pay, at least the Chancellor does not get it.
montyhedge
12/2/2019
13:55
I did not think they went that low yesterday. 1542?
zicopele
12/2/2019
08:20
I bought yesterday at 15.57pm, price 1542.856 …… ;0)
tradermichael
11/2/2019
22:20
Too high above £15
zicopele
11/2/2019
18:56
Could well be right. The damned thing has been very volatile share price wise for a blue chip company. I like the divi...but I hate looking at red on my portfolio. Watching and waiting....
funtimejonny
11/2/2019
18:13
After ex div I bet below 1500p, 1465p my target.
montyhedge
11/2/2019
17:14
I agree. It's a bit pricey right now. I have it on me watchlist but not buying at this price
funtimejonny
11/2/2019
11:45
Emma...you on first name terms TM? I do like your style. EMMA adds gravitas to your post. Meanwhile GSK is falling..it does tend to disappoint circa £16. Monty is right. Buy again sub £15.ex div. Leave the dividend for the longs. PS what is a green baseline?
zicopele
11/2/2019
11:33
The level and timing of GSK investments in Immuno-oncology is a strong indication that there's a massive opportunity here. Acquisition of Tesaro likely to tie in with the Merck partnership, and new R&D chief Hal Barron and Emma have it all planned with a faster track to the market than starting with a green baseline.
tradermichael
11/2/2019
10:59
A lot of hope and a lot of debt 20BN. GSK is not a corporate bond. A little bad news on the deep science of Tesaro and there goes your yield.
zicopele
11/2/2019
10:48
monty: "because I know when ex div, they always fall," Not always, and always not for long if it does!
tradermichael
11/2/2019
10:46
I like the ord share, but even a great company bought at the wrong price is a bad investment, sold at 1560p foregoing the div, because I know when ex div, they always fall, I think I will get these back at 1465p.Shares of course should be quite firm leading up to ex div.
montyhedge
11/2/2019
09:29
All depends if you got in at the start, it was there 5.25% if your late to the party of course you won't get much.
montyhedge
11/2/2019
09:26
The 5.25% 2033 presumably redeems at 100 so are trading around 1/3rd higher than redemption price so yield to maturity is nowhere near 5.25%. Haven’t done the maths, but looks like it probably yields under 2% over the remaining life taking into account the redemption loss.
scburbs
11/2/2019
09:23
OK - as you know, there are plenty of peaks and troughs to sell and buy as this share swings and rarely goes anywhere in a straight line - good luck.
tradermichael
11/2/2019
09:13
I will stick around TM. want to buy back on the dips. Should be lower at some stage in the next two weeks. That debt of 20bn is a concern until it is not a concern A Brexit deal might strengthen sterling and that will be bad. I presume all the longs on this board here are brexiteers
zicopele
11/2/2019
09:00
Goodbye zicopele - never thought this share suited you ;o)
tradermichael
11/2/2019
08:57
Thought you would have waited until ex d.
montyhedge
11/2/2019
08:36
Monty...I have sold...the debts are enormous.
zicopele
11/2/2019
08:08
Yes, but you can write the script now, until ex div they will be firm, go ex d then back below 1500p.
montyhedge
11/2/2019
08:07
GlaxoSmithKline (LON:GSK) had its target price increased by HSBC from GBX 1,820 ($23.78) to GBX 1,860 ($24.30) in a report released last Thursday. HSBC currently has a buy rating on the stock.
tradermichael
11/2/2019
07:43
The 5.25% 2033.
montyhedge
Chat Pages: Latest  771  770  769  768  767  766  765  764  763  762  761  760  Older
ADVFN Advertorial
Your Recent History
LSE
GSK
Glaxosmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200329 16:12:22